Indivior gets breather after court extends order blocking generic rival
Updated : June 29, 2018 03:40 PM IST
Dr. Reddy's and US-based Mylan NV received approval from the Food and Drug Administration (FDA) earlier this month to launch a generic version of Suboxone Film, which generates 80 percent of Indivior's revenue, forcing the UK company to file an injunction against the decision.
Indivior said its temporary restraining order (TRO) issued on June 15 had been extended for another 14 days, during which time the US court for the District of New Jersey will consider the application and issue a ruling on the injunction.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more